ATE320449T1 - Fusionsprotein mit verbesserter in vivo erythropoietinwirkung - Google Patents

Fusionsprotein mit verbesserter in vivo erythropoietinwirkung

Info

Publication number
ATE320449T1
ATE320449T1 AT01270554T AT01270554T ATE320449T1 AT E320449 T1 ATE320449 T1 AT E320449T1 AT 01270554 T AT01270554 T AT 01270554T AT 01270554 T AT01270554 T AT 01270554T AT E320449 T1 ATE320449 T1 AT E320449T1
Authority
AT
Austria
Prior art keywords
fusion protein
vivo
erythropoiety
improved
effect
Prior art date
Application number
AT01270554T
Other languages
English (en)
Inventor
Dong-Eok Lee
Myung-Suk Oh
Ki-Wan Kim
Bo-Sup Chung
Byung-Jhip Ha
Ji-Sook Park
Original Assignee
Cheil Jedang Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from KR1020010072713A external-priority patent/KR101229995B1/ko
Application filed by Cheil Jedang Corp filed Critical Cheil Jedang Corp
Application granted granted Critical
Publication of ATE320449T1 publication Critical patent/ATE320449T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/59—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g.hCG [human chorionic gonadotropin]; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/505—Erythropoietin [EPO]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Endocrinology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Reproductive Health (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT01270554T 2000-12-11 2001-12-10 Fusionsprotein mit verbesserter in vivo erythropoietinwirkung ATE320449T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR20000075230 2000-12-11
KR1020010072713A KR101229995B1 (ko) 2000-12-11 2001-11-21 생체내 에리스로포이에틴 활성이 증진된 융합단백질

Publications (1)

Publication Number Publication Date
ATE320449T1 true ATE320449T1 (de) 2006-04-15

Family

ID=36178279

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01270554T ATE320449T1 (de) 2000-12-11 2001-12-10 Fusionsprotein mit verbesserter in vivo erythropoietinwirkung

Country Status (6)

Country Link
EP (1) EP1342730B1 (de)
JP (1) JP3946638B2 (de)
AT (1) ATE320449T1 (de)
AU (1) AU2002222740A1 (de)
DE (1) DE60117919T2 (de)
WO (1) WO2002048194A1 (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100467751B1 (ko) 2001-12-03 2005-01-24 씨제이 주식회사 생체내 에리스로포이에틴 활성이 증진된 융합단백질
US20040009902A1 (en) * 2002-05-13 2004-01-15 Irving Boime CTP extended erythropoietin
US7625564B2 (en) 2006-01-27 2009-12-01 Novagen Holding Corporation Recombinant human EPO-Fc fusion proteins with prolonged half-life and enhanced erythropoietic activity in vivo
US9458444B2 (en) 2006-02-03 2016-10-04 Opko Biologics Ltd. Long-acting coagulation factors and methods of producing same
US7553941B2 (en) 2006-02-03 2009-06-30 Modigene Inc Long-acting polypeptides and methods of producing same
US8048849B2 (en) 2006-02-03 2011-11-01 Modigene, Inc. Long-acting polypeptides and methods of producing same
US8946155B2 (en) 2006-02-03 2015-02-03 Opko Biologics Ltd. Long-acting polypeptides and methods of producing and administering same
US10351615B2 (en) 2006-02-03 2019-07-16 Opko Biologics Ltd. Methods of treatment with long-acting growth hormone
US10221228B2 (en) 2006-02-03 2019-03-05 Opko Biologics Ltd. Long-acting polypeptides and methods of producing and administering same
US20140113860A1 (en) 2006-02-03 2014-04-24 Prolor Biotech Ltd. Long-acting polypeptides and methods of producing and administering same
US8450269B2 (en) 2006-02-03 2013-05-28 Prolor Biotech Ltd. Long-acting growth hormone and methods of producing same
US8476234B2 (en) 2006-02-03 2013-07-02 Prolor Biotech Inc. Long-acting coagulation factors and methods of producing same
US8759292B2 (en) 2006-02-03 2014-06-24 Prolor Biotech, Llc Long-acting coagulation factors and methods of producing same
US9249407B2 (en) 2006-02-03 2016-02-02 Opko Biologics Ltd. Long-acting coagulation factors and methods of producing same
US20150038413A1 (en) 2006-02-03 2015-02-05 Opko Biologics Ltd. Long-acting polypeptides and methods of producing and administering same
BRPI0814465B1 (pt) 2007-07-26 2021-11-23 Novagen Holding Corporation Proteína de fusão, dímero, método para produzir uma proteína de fusão, linhagem de célula, usos de uma proteína de fusão e de uma composição farmacêutica e composição farmacêutica
US12203113B2 (en) 2009-07-09 2025-01-21 Opko Biologics Ltd. Long-acting coagulation factors and methods of producing same
US9663778B2 (en) 2009-07-09 2017-05-30 OPKO Biologies Ltd. Long-acting coagulation factors and methods of producing same
HK1207564A1 (en) 2012-04-19 2016-02-05 Opko Biologics Ltd Long-acting oxyntomodulin variants and methods of producing same
HUE055348T2 (hu) 2012-11-20 2021-11-29 Opko Biologics Ltd Eljárás polipeptidek hidrodinamikus térfogatának növelésére gonadotropin karboxil-terminális peptidekhez való kapcsolással
CN103864913A (zh) * 2012-12-18 2014-06-18 联亚生技开发股份有限公司 重组蛋白
EP2968391A1 (de) 2013-03-13 2016-01-20 Moderna Therapeutics, Inc. Langlebige polynukleotidmoleküle
US20150158926A1 (en) 2013-10-21 2015-06-11 Opko Biologics, Ltd. Long-acting polypeptides and methods of producing and administering same
EP3230309B1 (de) 2014-12-10 2023-03-29 OPKO Biologics Ltd. Verfahren zur herstellung langwirkender ctp-modifizierter wachstumshormonpolypeptide
PL3310347T3 (pl) 2015-06-19 2021-12-27 Opko Biologics Ltd. Długo działające czynniki krzepnięcia i sposoby wytwarzania
MY206271A (en) 2016-07-11 2024-12-06 Opko Biologics Ltd Long-acting coagulation factor vii and methods of producing same

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3045539B2 (ja) * 1989-02-21 2000-05-29 ワシントン ユニバーシティ 改変型生殖ホルモン
US5792460A (en) * 1989-02-21 1998-08-11 Washington University Modified glycoprotein hormones having a CTP at the amino terminus
US6225449B1 (en) * 1991-10-04 2001-05-01 Washington University Hormone analogs with multiple CTP extensions
JPH07501450A (ja) * 1991-11-29 1995-02-16 モンサント　カンパニー 環状ジグアニレート代謝酵素
DE69422169D1 (de) * 1993-04-20 2000-01-20 Univ St Louis Modifizierte proteine und peptide enthaltende pharmazeutische mittel
CN1057534C (zh) * 1993-08-17 2000-10-18 柯瑞英-艾格公司 促红细胞生成素类似物
JO2291B1 (en) * 1999-07-02 2005-09-12 اف . هوفمان لاروش ايه جي Erythropoietin derivatives

Also Published As

Publication number Publication date
DE60117919D1 (de) 2006-05-11
WO2002048194A1 (en) 2002-06-20
EP1342730A1 (de) 2003-09-10
JP2004515246A (ja) 2004-05-27
JP3946638B2 (ja) 2007-07-18
DE60117919T2 (de) 2006-12-14
AU2002222740A1 (en) 2002-06-24
EP1342730B1 (de) 2006-03-15
EP1342730A4 (de) 2004-06-23

Similar Documents

Publication Publication Date Title
ATE320449T1 (de) Fusionsprotein mit verbesserter in vivo erythropoietinwirkung
BR0203386A (pt) Proteìna de fusão, ácido nucleico codificador e método para a preparação de uma proteìna de fusão possuindo uma melhorada atividade epo in-vivo
RU2002123286A (ru) Слитый белок с увеличенной эритропоэтиновой активностью, нуклеиновая кислота, кодирующая слитый белок, и способ получения слитого белка
NO20016243D0 (no) Anti-alfav-beta3-rekombinante humane antistoffer, nukleinsyrer som koder for de samme og fremgangsmåter foranvendelse
WO2003094849A3 (en) Ferritin fusion proteins for use in vaccines and other applications
ECSP064643A (es) Proteinas de fusion de glp-1
CA2237296A1 (en) Process for the preparation of peptides by way of streptavidin fusion proteins
EE200300100A (et) Polüpeptiid, selle kodeerivat nukleotiidjärjestust sisaldav nukleiinhape, vektor ja peremeesrakk, meetod polüpeptiidi valmistamiseks ning farmatseutiline kompositsioon
AR036384A1 (es) Una proteina de fusion que tiene actividad de eritropoyetina in vivo aumentada
CO4650184A1 (es) POLIPEPTIDOS DE FUSION QUE COMPRENDEN UN DOMINIO DE UNION DE IgE Y UN COMPONENTE DE SEROALBUMINA HUMANA
WO2002059315A3 (en) Human nucleic acids and polypeptides and methods of use thereof
AU2003252111A8 (en) Fluorescent proteins, nucleic acids encoding them and methods for making and using them
DE60139113D1 (de) 18477, eine menschliche proteinkinase und deren verwendung
EE200000487A (et) Kaspaas-8 proteaasiga interakteeruv proteiin, seda kodeeriv DNA järjestus, selle valmistamis- ja identifitseerimismeetod ning kasutamine ravimi valmistamiseks
ATE199396T1 (de) Fusions-dns-sequenz, dadurch exprimiertes fusionsprotein und verfahren zur expression dieses fusionsproteins
AU2003226907A8 (en) Method for the preparation of recombinant mammalian heparin-binding protein (hbp)
AU654155B2 (en) A DNA encoding a protein which binds to the enhancer of alpha-fetoprotein gene
WO2002036633A3 (en) Human 7tm proteins and polynucleotides encoding the same
ATE335005T1 (de) Menschliches protein mit in vitro antiproliferativer aktivität.
WO2002016435A3 (en) Human 7tm proteins and polynucleotides encoding the same
WO2001072842A3 (en) Human 7-transmembrane proteins and polynucleotides encoding the same
AU2002245128A1 (en) Human transporter proteins, nucleic acid molecules encoding them, and uses thereof
WO1999055876A3 (de) Polypeptid mit immunogenen eigenschaften und veränderten biologischen funktionen eines proteins
EP1419251A4 (de) Isolierte menschliche transporterproteine, menschliche transporterproteine codierende nukleinsäuremoleküle sowie verwendungen davon
WO2001012788A3 (en) Tryptase-like polypeptide ztryp1

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties